Literature DB >> 6397385

Disappearance rate of insulin antibodies after discontinuing insulin treatment in 42 type 2 (non-insulin-dependent) diabetic patients.

C Ionescu-Tîrgovişte, I Mincu, L Simionescu, D Cheţa, Z Mirodon, E Sântu, E Popa, A Bîrnea.   

Abstract

The disappearance rate of insulin antibodies was studied after cessation of insulin treatment which had been given for 3 months to 6 years in 42 Type 2 (non-insulin-dependent) diabetic patients. Insulin antibodies were measured before and 15 days after interruption of insulin treatment, and every 30 days until the disappearance of insulin antibodies. The mean +/- SD value of insulin binding in the entire group before the interruption of insulin treatment was 32 +/- 14%. There was no relationship between the antibody level at that time and the duration of insulin treatment. However, the insulin antibody level was significantly higher in 17 diabetic patients on an insulin dose of greater than 20 U/day (p less than 0.02) than in 25 on an insulin dose of less than 20 U/day (39 +/- 13% versus 28 +/- 12%). A positive correlation was found between initial insulin binding and the time required for it to fall below 10% (r = 0.74). Antibodies were absent 60 days after discontinuing insulin treatment in eight of ten subjects presenting with initial binding of less than 20%. In contrast, in only two of 12 patients with an initial binding of greater than 40% were insulin antibodies detectable 150 days after discontinuation of insulin therapy. Disappearance of insulin antibodies sometimes took up to 1 year and occasionally even more than 2 years.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6397385     DOI: 10.1007/BF00276974

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  15 in total

1.  INSULIN RESISTANCE. DIFFERENTIATION INTO TWO TYPES BY MEASUREMENT OF SERUM INSULIN-LIKE ACTIVITY IN VITRO.

Authors:  J STEINKE; J S SOELDNER
Journal:  Diabetes       Date:  1965-07       Impact factor: 9.461

2.  Quantitative aspects of the reaction between insulin and insulin-binding antibody.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

3.  A method for the determination of plasma insulin antibodies and its application in normal and diabetic subjects.

Authors:  M Sebriakova; J A Little
Journal:  Diabetes       Date:  1973-01       Impact factor: 9.461

4.  Serological analysis of human IgG and IgE anti-insulin antibodies by solid-phase radioimmunoassays.

Authors:  R G Hamilton; M Rendell; N F Adkinson
Journal:  J Lab Clin Med       Date:  1980-12

Review 5.  Circulating insulin-binding antibodies.

Authors:  A B Kurtz; J D Nabarro
Journal:  Diabetologia       Date:  1980-10       Impact factor: 10.122

6.  Immunological response to the prolonged administration of heterologous and homologous insulin in cattle.

Authors:  A E Renold; J Steinke; J S Soeldner; H N Antoniades; R E Smith
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

7.  Determination of insulin specific IgE in serum of diabetic patients by solid-phase radioimmunoassay.

Authors:  K Falholt
Journal:  Diabetologia       Date:  1982-04       Impact factor: 10.122

8.  The bioavailability of circulating antibody-bound insulin following insulin withdrawal in Type 1 (insulin-dependent) diabetes.

Authors:  N J Vaughan; J A Matthews; A B Kurtz; J D Nabarro
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

9.  RIA measurement of insulin antibodies in human sera using the polyethyleneglycol separation technique.

Authors:  L Simionescu; M Oprescu; Z Mirodon
Journal:  Endocrinologie       Date:  1979 Jul-Sep

10.  Relationship of glycosylated haemoglobin to C-peptide secretory status and antibody binding of insulin in insulin-dependent diabetes.

Authors:  R S Gray; D Q Borsey; A Kurtz; S Rainbow; A F Smith; R A Elton; L J Duncan; B F Clarke
Journal:  Horm Metab Res       Date:  1981-11       Impact factor: 2.936

View more
  6 in total

1.  Frequent reoccurrence of hypoglycemia in a type 2 diabetic patient with insulin antibodies.

Authors:  Tie-Yun Zhao; Fang Li; Zhong-Yun Xiong
Journal:  Mol Diagn Ther       Date:  2010-08-01       Impact factor: 4.074

2.  A longitudinal study of insulin antibodies and anti-insulin cytotoxicity in type I diabetes mellitus.

Authors:  E R Richens; M E Seward; M Hartog; W A Luqman
Journal:  Acta Diabetol Lat       Date:  1987 Oct-Dec

3.  Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study.

Authors:  I Mühlhauser; I Bruckner; M Berger; D Cheţa; V Jörgens; C Ionescu-Tîrgovişte; V Scholz; I Mincu
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

4.  Immunological hypoglycemia associated with insulin antibodies induced by exogenous insulin in 11 Chinese patients with diabetes.

Authors:  Heng Quan; Huiwen Tan; Qianrui Li; Jianwei Li; Sheyu Li
Journal:  J Diabetes Res       Date:  2015-04-15       Impact factor: 4.011

Review 5.  Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients.

Authors:  Xiaolei Hu; Fengling Chen
Journal:  Endocr Connect       Date:  2017-12-12       Impact factor: 3.335

6.  Association of Higher Circulating Insulin Antibody with Increased Mean Amplitude Glycemic Excursion in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional, Retrospective Case-Control Study.

Authors:  Jian Zhu; Lu Yuan; Wen-Ji Ni; Yong Luo; Jian-Hua Ma
Journal:  J Diabetes Res       Date:  2019-03-18       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.